Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 4/20 | 0.65 |
| ▸ | USP2 | O75604 | 1/20 | 0.56 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.53 |
| ▸ | PTAFR | P25105 | 1/20 | 0.53 |
| ▸ | HTR1D | P28221 | 1/20 | 0.53 |
| ▸ | HTR2C | P28335 | 1/20 | 0.53 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.53 |
| ▸ | DRD3 | P35462 | 1/20 | 0.53 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.53 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.51 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.51 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.51 |
| ▸ | PLA2G2C | Q5R387 | 2/20 | 0.50 |
| ▸ | CES2 | O00748 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27795601 | 1.00 | PRKCA (0.65) | PRKCAUSP2ADRA1DPTAFRHTR1D | |
| SCHEMBL5493689 | 1.00 | PRKCA (0.65) | PRKCAUSP2ADRA1DPTAFRHTR1D | |
| SCHEMBL2732833 | 1.00 | PRKCA (0.65) | PRKCAUSP2ADRA1DPTAFRHTR1D | |
| SCHEMBL7411764 | 1.00 | PRKCA (0.65) | PRKCAUSP2ADRA1DPTAFRHTR1D | |
| SCHEMBL1009136 | 1.00 | PRKCA (0.65) | PRKCAUSP2ADRA1DPTAFRHTR1D | |
| SCHEMBL9436412 | 0.98 | PRKCA (0.62) | PRKCAUSP2ADRA1DPTAFRHTR1D | |
| SCHEMBL4324597 | 0.93 | PRKCA (0.59) | PRKCAUSP2ADRA1DPTAFRHTR1D | |
| SCHEMBL4912502 | 0.91 | PRKCA (0.62) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL4912512 | 0.91 | PRKCA (0.62) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL1000470 | 0.91 | PRKCA (0.62) | PRKCAPRKCEPRKCQPRKCDMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013105101-A1 | SOLID LIPID NANOPARTICLES ENTRAPPING HYDROPHILIC/ AMPHIPHILIC DRUG AND A PROCESS FOR PREPARING THE SAME | DEPARTMENT OF BIOTECHNOLOGY (IN) | 2013-07-18 | — | — | WO | claimed |
| EP-4351517-A1 | DRY POWDER FORMULATIONS OF EPINEPHRINE AND ASSOCIATED METHODS | Belhaven Biopharma Inc. (US) | 2024-04-17 | — | — | EP | disclosed |
| WO-2022261453-A1 | DRY POWDER FORMULATIONS OF EPINEPHRINE AND ASSOCIATED METHODS | Belhaven BioPharma Inc. (US) | 2022-12-15 | — | — | WO | disclosed |
| WO-2018170414-A1 | NON-VIRAL, NON-CATIONIC NANOPARTICLES AND USES THEREOF | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2018-09-20 | — | — | WO | disclosed |
| WO-2018170398-A1 | ENGINEERED LIPOSOMES AS CANCER-TARGETED THERAPEUTICS | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2018-09-20 | — | — | WO | disclosed |
| EP-2389157-A1 | DRUG DELIVERY SYSTEM FOR USE IN THE TREATMENT OF VASCULAR AND VESSEL-RELATED PATHOLOGIES | Academisch Medisch Centrum (NL) | 2011-11-30 | — | — | EP | disclosed |
| US-8038960-B2 | Improves thermal efficiency by heating both inner and outer side surfaces of double cylindrical reforming chamber by combustion gas produced when burner is turned on, and in the reforming chamber, providing \"return pipes\" through which a produced reformed gas flows | IDEMITSU KOSAN CO., LTD. (JP) | 2011-10-18 | — | — | US | disclosed |
| EP-2268272-A2 | COMPOUNDS THAT MODULATE NEGATIVE-SENSE, SINGLE-STRANDED RNA VIRUS REPLICATION AND USES THEREOF | Mount Sinai School of Medicine of New York University (US) | 2011-01-05 | — | — | EP | disclosed |
| WO-2010084199-A1 | DRUG DELIVERY SYSTEM FOR USE IN THE TREATMENT OF VASCULAR AND VESSEL-RELATED PATHOLOGIES | ACADEMISCH MEDISCH CENTRUM (NL) | 2010-07-29 | — | — | WO | disclosed |
| WO-2009136979-A2 | COMPOUNDS THAT MODULATE NEGATIVE-SENSE, SINGLE-STRANDED RNA VIRUS REPLICATION AND USES THEREOF | MOUNT SINAI SCHOOL OF MEDICINE OF NEW YORK UNIVERSITY (US) | 2009-11-12 | — | — | WO | disclosed |
| EP-0784430-A4 | METHOD FOR REDUCING UNWANTED CELLULAR ADHESIONS | ZYNAXIS INC (US) | 2000-10-11 | — | — | EP | disclosed |
| EP-0784430-A1 | METHOD FOR REDUCING UNWANTED CELLULAR ADHESIONS | Zynaxis Inc. (US) | 1997-07-23 | — | — | EP | disclosed |
| WO-1996010912-A1 | METHOD FOR REDUCING UNWANTED CELLULAR ADHESIONS | ZYNAXIS, INC. (US) | 1996-04-18 | — | — | WO | disclosed |